Skip to Main Content

Author Details

James R Rogers
Columbia University
2015
32
14
PMIDPaper TitleJournal TitlePublished Year
35189334Leveraging electronic health record data for clinical trial planning by assessing eligibility criteria's impact on patient count and safety.J Biomed Inform2022
35486806Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis.JMIR Public Health Surveill2022
36257483Deep learning for rare disease: A scoping review.J Biomed Inform2022
33260201Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials.J Am Med Inform Assoc2021
33828278AI uses patient data to optimize selection of eligibility criteria for clinical trials.Nature2021
33825838Comparison of Clinical Characteristics Between Clinical Trial Participants and Nonparticipants Using Electronic Health Record Data.JAMA Netw Open2021
34496418A Framework for Systematic Assessment of Clinical Trial Population Representativeness Using Electronic Health Records Data.Appl Clin Inform2021
34642696A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections - Risk Factors and Vaccine Effectiveness.medRxiv2021
34044156Clinical comparison between trial participants and potentially eligible patients using electronic health record data: A generalizability assessment method.J Biomed Inform2021
34344671Published models that predict hospital readmission: a critical appraisal.BMJ Open2021
33164065Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review.J Am Med Inform Assoc2021
31889182Understanding the nature and scope of clinical research commentaries in PubMed.J Am Med Inform Assoc2020
31065558A Data Element-Function Conceptual Model for Data Quality Checks.EGEMS (Wash DC)2019
31655273Ensembles of natural language processing systems for portable phenotyping solutions.J Biomed Inform2019
30066315Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration's Adverse Event Reporting System.Drug Saf2019
31243156Stepped-wedge randomised trial to evaluate population health intervention designed to increase appropriate anticoagulation in patients with atrial fibrillation.BMJ Qual Saf2019
30865626Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.PLoS Med2019
29168261"Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".Pharmacoepidemiol Drug Saf2018
30001251Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10.Med Care2018
30156128Characteristics of early sacubitril/valsartan patients and considerations for studies in electronic health record data.J Comp Eff Res2018
30074538Data Mining for Adverse Drug Events With a Propensity Score-matched Tree-based Scan Statistic.Epidemiology2018
29673963No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study.Semin Arthritis Rheum2018
29447776The relative benefits of claims and electronic health record data for predicting medication adherence trajectory.Am Heart J2018
29615391Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.BMJ2018
29438436Assessment of coronary vascular function with cardiac PET in relation to serum uric acid.PLoS One2018
27375290Use of electronic healthcare records to identify complex patients with atrial fibrillation for targeted intervention.J Am Med Inform Assoc2017
28245350Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study.Arthritis Rheumatol2017
29087983Adaptation and Validation of the Combined Comorbidity Score for ICD-10-CM.Med Care2017
25732494Mandatory disclaimers on dietary supplements do not reliably communicate the intended issues.Health Aff (Millwood)2015
25884398Bisphosphonates and risk of cardiovascular events: a meta-analysis.PLoS One2015
26686791Comparison of Benefit-Risk Assessment Methods for Prospective Monitoring of Newly Marketed Drugs: A Simulation Study.Value Health2015
26686792Prospective Benefit-Risk Monitoring of New Drugs for Rapid Assessment of Net Favorability in Electronic Health Care Data.Value Health2015
  • 1 - 32 of 32

Recommended Authors

Andrew E Williams
Tufts, Tufts Medical Center
Career Start Year 2018
Number of shared co-authors 7
Justin F Rousseau
University of Texas at Austin
Career Start Year 2018
Number of shared co-authors 1
Zhaoyi Chen
University of Florida
Career Start Year 2017
Number of shared co-authors 1
Clair Blacketer
Erasmus University Medical Center
Career Start Year 2016
Number of shared co-authors 3
Jenna M Reps
Erasmus University Medical Center
Career Start Year 2014
Number of shared co-authors 4
Rupa Makadia
Janssen Pharmaceutical Research and Development
Career Start Year 2014
Number of shared co-authors 6
Gloria Lipori
University of Florida Health
Career Start Year 2014
Number of shared co-authors 3
Erica A Voss
Erasmus University Medical Center
Career Start Year 2014
Number of shared co-authors 3
Ruijun Chen
USA Tempus Labs Inc.
Career Start Year 2012
Number of shared co-authors 3
Frank DeFalco
Janssen Pharmaceutical Research & Development
Career Start Year 2011
Number of shared co-authors 5
Christian Reich
OHDSI Center at The Roux Institute, Northeastern University
Career Start Year 2010
Number of shared co-authors 7
Azza Shoaibi
Janssen Pharmaceutical Research and Development
Career Start Year 2010
Number of shared co-authors 3
Sanket S Dhruva
University of California san francisco
Career Start Year 2008
Number of shared co-authors 2
Spiros Denaxas
Institute of Health Informatics, University College London
Career Start Year 2008
Number of shared co-authors 3
Scott L DuVall
University of Utah
Career Start Year 2006
Number of shared co-authors 5
Jeremy A Rassen
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 8
Vojtech Huser
Lister Hill National Center for Biomedical Communication
Career Start Year 2005
Number of shared co-authors 7
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 4
Terrence J Adam
University of Minnesota, Institute for Health Informatics.
Career Start Year 2002
Number of shared co-authors 0
Nilay D Shah
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 3
Nigam H Shah
Stanford University
Career Start Year 2002
Number of shared co-authors 11
Rebecca N Jerome
12328Vanderbilt University Medical Center
Career Start Year 2001
Number of shared co-authors 0
Josh F Peterson
Vanderbilt University Medical Center
Career Start Year 2001
Number of shared co-authors 5
Martijn J Schuemie
University of California los angeles
Career Start Year 2001
Number of shared co-authors 9
Joseph S Ross
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 2
Tina Hernandez-Boussard
Stanford University
Career Start Year 1998
Number of shared co-authors 0
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 3
David Madigan
Columbia University.
Career Start Year 1990
Number of shared co-authors 5
Mark G Weiner
Weill Cornell Medical College
Career Start Year 1987
Number of shared co-authors 5
Ida Sim
University of California San Francisco
Career Start Year 1985
Number of shared co-authors 3

Collaborators

Chunhua Weng
Columbia University Irving Medical Center
Co-authored papers 13
Joshua J Gagne
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Co-authored papers 9
Casey N Ta
Columbia University Irving Medical Center
Co-authored papers 6
Sebastian Schneeweiss
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Co-authored papers 6
Aaron S Kesselheim
Brigham and Women's Hospital.
Co-authored papers 4
George Hripcsak
Columbia University
Co-authored papers 4
Shirley V Wang
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 4
Ameet Sarpatwari
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Co-authored papers 3
Rishi J Desai
Harvard Medical School
Co-authored papers 3
Justin Bohn
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 3
Karthik Natarajan
Columbia University Irving Medical Center
Co-authored papers 2
Sengwee Toh
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 2
Cynthia Sung
Health Services and Systems Research, Duke-NUS Medical School
Co-authored papers 1
Patrick B Ryan
Columbia University Irving Medical Center
Co-authored papers 1
Liwei Wang
University of Texas Health Science Center at Houston, Mayo Clinic
Co-authored papers 1
Jeffrey S Brown
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 1
Nishant R Shah
Brown University Alpert Medical School
Co-authored papers 1
Hojjat Salmasian
Brigham and Women's Hospital
Co-authored papers 1
Wendy K Chung
Boston Children's Hospital, Harvard Medical School
Co-authored papers 1
Colin G Walsh
Vanderbilt University, Vanderbilt University Medical Center
Co-authored papers 1
David K Vawdrey
Columbia University
Co-authored papers 1
Ritu Khare
Co-authored papers 1
Mitchell S V Elkind
Vagelos College of Physicians and Surgeons (D.Y., Columbia University
Co-authored papers 1
Michael Nguyen
Center for Drug Evaluation and Research
Co-authored papers 1
Yehoshua Perl
New Jersey Institute of Technology
Co-authored papers 1
Lisa Grossman Liu
Columbia University
Co-authored papers 1
Devan Kansagara
Center for the Involvement of Veterans in their Care (CIVIC)
Co-authored papers 1
David W Bates
Brigham and Women's Hospital Division of General Internal Medicine
Co-authored papers 1
Feichen Shen
Shanghai Polytechnic University
Co-authored papers 1
David W Bates
Harvard Medical School
Co-authored papers 1
Release 1.2